Introduction
DaRe2THINK is a transformational project that will test a new way of running clinical trials at General Practices in the NHS. The trial will use health information already collected in the NHS to reduce the burden of research, for both patients and NHS staff. This will allow the NHS to reach new and larger groups of patients that could benefit from new treatments opening the possibility of research to populations that would not have previously taken part.
Testing New Therapies
AF is a common heart rhythm condition that leads to a high chance of stroke, frequent hospital admissions and poor quality of life. Patients can also develop trouble remembering, concentrating or making every-day decisions that can lead to dementia. Blood thinning tablets, or anticoagulants, greatly reduce the number of patients with AF that will suffer a stroke but are usually only given to older patients or those with other health issues.
DaRe2THINK will test if a newer class of blood thinning tablets widely used in the NHS are cost-effective in younger patients with AF and can reduce the devastating impact of stroke and other blood clots.
Discover More ...
Use the links below to see tailored content for Healthcare Professionals and Patients, or find out more about results associated with the DaRe2THINK study